Bjorkman, Pamela J.
- Kubinski, Hannah C. and Despres, Hannah W., et el. (2024) Variant mutation in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation; bioRxiv; 53; PMCID PMC10979914; 10.1101/2024.03.08.584120
- Cohen, Alexander A. and van Doremalen, Neeltje, et el. (2023) Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal models; PMCID PMC8978945; 10.1101/2022.03.25.485875
- Gristick, Harry B. and Hartweger, Harald, et el. (2023) CD4-binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wildtype animals; 10.1101/2022.09.08.507086
- Braet, Sean M. and Buckley, Theresa S. C., et el. (2023) Timeline of changes in spike conformational dynamics in emergent SARS-CoV-2 variants reveal progressive stabilization of trimer stalk and enhanced NTD dynamics; 10.1101/2022.08.26.505369
- Hills, Rory A. and Tan, Tiong Kit, et el. (2023) Multiviral Quartet Nanocages Elicit Broad Anti-Coronavirus Responses for Proactive Vaccinology; PMCID PMC9980174; 10.1101/2023.02.24.529520
- Dam, Kim-Marie A. and Fan, Chengcheng, et el. (2023) Structural characterization of HIV-1 Env heterotrimers bound to one or two CD4 receptors reveals intermediate Env conformations; 10.1101/2023.01.27.525985
- Hoffmann, Magnus A. G. and Yang, Zhi, et el. (2023) ESCRT recruitment to mRNA-encoded SARS-CoV-2 spike induces virus-like particles and enhanced antibody responses; PMCID PMC9810232; 10.1101/2022.12.26.521940
- Yang, Zhi and Dam, Kim-Marie A., et el. (2022) Antibody recognition of CD4-induced open HIV-1 Env trimers; 10.1101/2022.07.27.501785
- Fan, Chengcheng and Cohen, Alexander A., et el. (2022) Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes; 10.1101/2022.06.28.497989
- Dam, Kim-Marie A. and Barnes, Christopher O., et el. (2022) HIV-1 CD4-binding site germline antibody-Env structures inform vaccine design; 10.1101/2022.03.25.485873
- Muecksch, Frauke and Weisblum, Yiska, et el. (2021) Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies; PMCID PMC7987023; 10.1101/2021.03.07.434227
- Barnes, Christopher O. and Jette, Claudia A., et el. (2020) Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies; 10.1101/2020.08.30.273920
- Einav, Tal and Yazdi, Shahrzad, et el. (2020) Harnessing Avidity: Quantifying Entropic and Energetic Effects of Linker Length and Rigidity Required for Multivalent Binding of Antibodies to HIV-1 Spikes; 10.1101/406454
- Einav, Tal and Gnanapragasam, Priyanthi N. P., et el. (2018) Modeling Entropic and Energetic Effects of Linker Length and Rigidity within Synthetic HIV-1 Antibodies designed to Bind Bivalently to Env Spikes; 10.1101/406454
- Chuang, Gwo-Yu and Zhou, Jing, et el. (2018) Structural survey of HIV-1-neutralizing antibodies targeting Env trimer delineates epitope categories and suggests vaccine templates; 10.1101/312579
- Galimidi, Rachel P. and Einav, Tal, et el. (2018) Quantifying the Entropic and Energetic Effects of Linker Length and Rigidity within Synthetic HIV-1 Antibodies designed to Bind Bivalently to Env Spikes; 10.1101/406454